Literature DB >> 12468898

Prognostic factors for functional independence in older adults with mild dementia: results from the canadian study of health and aging.

Anne Perrault1, Christina Wolfson, Mary Egan, Kenneth Rockwood, David B Hogan.   

Abstract

We investigated the prevalence of and prognostic factors for functional independence in personal activities of daily living in a population-based sample of 90 seniors with mild dementia from the Canadian Study of Health and Aging. Personal activities of daily living were assessed from the report of proxy respondents at baseline and at the 5-year follow-up (or retrospectively if death had occurred). Sixteen (17.8% of the total group of 90) subjects maintained their personal activities of daily living independence over the full 5-year period or up to 3 months before death (15.1% if the four subjects reclassified as not demented at the second wave are excluded). An age of 75-84 years (vs. those 65-74 years of age and 85+ years of age; odds ratio 12.9, 95% confidence interval 2.7, 112.7), the absence of gait-balance-movement problems (odds ratio 5.2, 95% confidence interval 1.3, 25.8), the presence of extrapyramidal signs (odds ratio 9.5), and fewer years of formal education (odds ratio 3.6) were favorable prognostic factors in our multivariate modeling. An absence of sensory problems was a statistically significant favorable prognostic factor in bivariate analysis. Prior studies on the time required for patients with dementia to progress to functional milestones used clinic-based samples. Our findings, which have potential public health implications, need to be confirmed and expanded upon.

Entities:  

Mesh:

Year:  2002        PMID: 12468898     DOI: 10.1097/00002093-200210000-00005

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  4 in total

1.  The predictive validity of the 10/66 dementia diagnosis in Chennai, India: a 3-year follow-up study of cases identified at baseline.

Authors:  A T Jotheeswaran; Joseph D Williams; Martin J Prince
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jul-Sep       Impact factor: 2.703

Review 2.  Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.

Authors:  David B Hogan
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

3.  Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease.

Authors:  Atul Kumar; Maryam Shoai; Sebastian Palmqvist; Erik Stomrud; John Hardy; Niklas Mattsson-Carlgren; Oskar Hansson
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

4.  Promoting independence in Lewy body dementia through exercise: the PRIDE study.

Authors:  Michael J Inskip; Yorgi Mavros; Perminder S Sachdev; Jeffrey M Hausdorff; Inbar Hillel; Maria A Fiatarone Singh
Journal:  BMC Geriatr       Date:  2022-08-09       Impact factor: 4.070

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.